Cargando…
Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is the only curative modality. Fluorescence-enhanced visualization of CRC with targeted fluorescent probes that can delineate boundaries and target tumor-specific biomarkers can increase rates of curative resection...
Autores principales: | Lwin, Thinzar M., Turner, Michael A., Amirfakhri, Siamak, Nishino, Hiroto, Hoffman, Robert M., Bouvet, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773892/ https://www.ncbi.nlm.nih.gov/pubmed/35053365 http://dx.doi.org/10.3390/cells11020249 |
Ejemplares similares
-
Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer
por: Lwin, Thinzar M., et al.
Publicado: (2022) -
The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review
por: Turner, Michael A., et al.
Publicado: (2021) -
Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model
por: Nishino, Hiroto, et al.
Publicado: (2022) -
Specific Targeting and Labeling of Colonic Polyps in CPC-APC Mice with Mucin 5AC Fluorescent Antibodies: A Model for Detection of Early Colon Cancer
por: Turner, Michael A., et al.
Publicado: (2023) -
Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery
por: Lwin, Thinzar M., et al.
Publicado: (2021)